title: Insulin storage in Europe: a comment to Grajower et al., Eli Lilly, and Novo Nordisk.
authors.affiliation: Diabetes Unit, Chivasso Civic Hospital, Turin, Italy. diabetologia@asl7.to.it
authors.forename: Marco
authors.initials: M
authors.lastname: Gallo
authors.forename: Marco
authors.initials: M
authors.lastname: Comoglio
authors.forename: Alberto
authors.initials: A
authors.lastname: De Micheli
authors.forename: Luca
authors.initials: L
authors.lastname: Monge
authors.forename: Giacomo
authors.initials: G
authors.lastname: Vespasiani
mesh_terms: D003920:Diabetes Mellitus / Q000188:drug therapy; D004349:Drug Packaging / Q000379:methods*; D004355:Drug Stability; D005060:Europe; D006801:Humans; D007004:Hypoglycemic Agents / Q000008:administration & dosage / Q000592:standards / Q000627:therapeutic use; D007328:Insulin / Q000008:administration & dosage / Q000592:standards / Q000627:therapeutic use*
chemical_list: D007004:Hypoglycemic Agents; D007328:Insulin